When Should You Buy WuXi AppTec Co., Ltd. (SHSE:603259)?

Simply Wall St19:53 ET

Statistics of open short positions in Hong Kong stocks | January 24

Zhitong Hong Kong Stock Shorts | January 24

Zhitong FinanceJan 24 05:30 ET

Express News | Citigroup's Long Position in H-Shares of WuXi AppTec Increases to 5.20% on Jan 20 From 4.26% - HKEX

ReutersJan 24 04:42 ET

Hong Kong stocks movement | CRO Concept stocks rose broadly in the morning as Innovative Drugs continue to expand overseas. The Global interest rate cuts help improve CXO overseas Business.

CRO Concept stocks experienced a general rise in the morning session. As of the time of writing, FRONTAGE (01521) rose by 5.88%, trading at 1.8 HKD; WUXI APPTEC (02359) rose by 4.97%, trading at 57 HKD; WUXI BIO (02269) rose by 3.64%, trading at 18.2 HKD; PHARMARON (03759) rose by 3.21%, trading at 14.14 HKD.

Zhitong FinanceJan 23 21:50 ET

【Brokerage Focus】CITIC SEC指出今年是在底部布局医疗健康产业优秀赛道和头部核心企业的最佳机会.

Golden Owl Finance | CITIC SEC stated that the 43rd J.P. Morgan Healthcare Conference will be held from January 13 to 16, 2025, in San Francisco, USA. As the largest and most content-rich healthcare investment seminar in the industry, it brings together global industry leaders, rapidly growing emerging companies, innovative technology creators, and investment professionals. According to the exchanges disclosed by participating companies, specifically, in the area of Innovative Drugs, the technological iteration and business development around core products/fields remain the growth engines for Pharma; in the CXO and upstream life sciences sector, upstream research and development needs are showing moderate recovery.

Jinwu Financial NewsJan 23 19:53 ET

WuXi AppTec Updates Board Composition for Strategic Governance

TipRanksJan 22 06:08 ET